UpFront

Contributed by:

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Awards… Cephalon wins PRSA Awards CRF Health Wins at Clio Natrel Wins Rx Club Award INDUSTRY at Large Smarty Apps… E-Promotion on the E-Rise Supporting Science Education Lucky 14 Pharma Saves Green by Going Green

Disruptive Technology, Disruptive times

Top Innovators Podcasts Best Practices for Your CRO ­Partnerships Thought Leader: Colin Terry, Aptuit A New Wellness-Centric Ecosystem Thought Leaders: Dr. Elby Nash and ­Nagaraja ­Srivatsan, Cognizant CEE: The Other Growth Opportunity Thought Leader: Pali F. Kollath DVM, ­Kantar How Integrated Solutions Can ­Optimize ­Clinical Research Thought Leader: James DeSanti, ­PharmaVigilant Redefining CRM Thought Leaders: Katie Mihelich and Danielle Jamil, Siren Whitepapers Maximizing the Success of Your CRO ­Partnerships Sponsored by: Aptuit Cancer Treatment in China: Implications and Opportunities for Pharma Sponsored by: Kantar CEE: The Other Growth Opportunity Sponsored by: Kantar 3 Critical Elements of CRM in Rare ­Disorder Marketing Sponsored by: Siren Milestones… » Cephalon wins PRSA Awards Cephalon swept the 2010 PRSA ­Philadelphia Pepperpot Awards. The company won best in show and first place for When Good Medicines ­Become Bad Drugs, an ­educational program on the ­responsible use of medicines. The agency partner is Vox Medica. » CRF Health Wins at Clio CRF Health’s ­ad ­campaign, No One Gets You Closer, which focuses on the ­collection of clean patient data for use in clinical trials, recently received awards at both the Clio Healthcare Awards and the Rx Awards. » Natrel Wins Rx Club Award Natrel Communications has been awarded an Rx Club Award of ­Excellence for Global Branding Guidelines developed for the CSL Behring brand, Hizentra. Supporting Science Education Teach For America and the Amgen Foundation have renewed their partnership to advance math and science education in America’s underserved public schools. The Amgen Foundation pledged $1.8 million bringing the total support to more than $7 million since 2004. Each year, the Amgen Foundation ­supports 100 new Amgen Fellows, selected from the top incoming Teach For America corps members with undergraduate degrees in math or science. An $1.8 million grant will enable Teach For America to recruit and train more math and science graduates to join the ­teaching corps. Smarty Apps… Pri-Med reports ­mobile adoption among young doctors, under the age of 35, exceeds their older counterparts, 55 and older, by more than two times. E-Promotion on the E-Rise According to SDI, industrywide, more than 3.4 million e-promotional activities took place and $396 million was spent on e-promotion during the first nine months of 2010. More than 150 drugs were marketed using online ­details and events for the first time in 2010. “We’re active partners in ­supporting the improvement of health and health ­awareness education throughout China, even in remote provinces. ” Joe Jimenez / ­Novartis Podcasts Best Practices for Your CRO ­Partnerships Thought Leader: Colin Terry, Aptuit A New Wellness-Centric Ecosystem Thought Leaders: Dr. Elby Nash and ­Nagaraja ­Srivatsan, Cognizant CEE: The Other Growth Opportunity Thought Leader: Pali F. Kollath DVM, ­Kantar How Integrated Solutions Can ­Optimize ­Clinical Research Thought Leader: James DeSanti, ­PharmaVigilant Redefining CRM Thought Leaders: Katie Mihelich and Danielle Jamil, Siren Whitepapers Maximizing the Success of Your CRO ­Partnerships Sponsored by: Aptuit Cancer Treatment in China: Implications and Opportunities for Pharma Sponsored by: Kantar CEE: The Other Growth Opportunity Sponsored by: Kantar 3 Critical Elements of CRM in Rare ­Disorder Marketing Sponsored by: Siren » BioClinica, a global provider of clinical trial management services, is celebrating 20 years of experience, leadership, and growth. Among its many milestones ­during its 20th anniversary, BioClinica launched Trident IWR in October; released a new version of Optimizer; acquired TranSenda International LLC; launched a new version of WebSend; and launched Trial Blazers. » Williams-Labadie, part of Publicis Healthcare Communications Group (PHCG) celebrated its 20th ­anniversary. “While we’re happy to celebrate 20 years in the healthcare advertising and communications business, we’re even more excited about the potential new media, digital communications, and ­analytics that we will be providing to our clients over the next 20 years,” says Peter Labadie, ­managing director. Editor’s Note: Stay tuned for PharmaVOICE’s 10th Anniversary special March issue. Disruptive Technology, Disruptive times Unisys predicts that in the next year, there will be up to six disruptive technology trends that will reshape the IT industry. One of these is cloud computing, which is expected to ­accelerate from pilots to production, with private clouds leading the way. This, Unisys says, will be a key stepping stone to broader use of public cloud environments over the next two to three years. Pharma Saves Green by Going Green According to Industrial Information Resources’ ­Pharmaceutical Tracker, there are currently 162 life-sciences projects in North America valued at more than $13.8 billion using LEED construction practices. Although universities and other institutions garner a large portion of this segment, pharmaceutical ­companies are also well represented. For example, Gilead Sciences is expanding and renovating its ­Foster City, Calif., site with more than 1 million square feet of LEED-Silver space. Tufts CSDD says the cost of ­developing a new drug is higher than ever — about $1.3 billion. Safety is a priority for the ­development of all medicines, but some say biologics raise safety ­considerations beyond those of chemical drugs. Do you believe ­biosimilars pose patient safety ­concerns? Yes / No / Maybe { Reply to feedback@pharmavoice.com with your response. PharmaVOICE wants to know what sponsors and CROs are doing to adapt to the recent ­ruling. { Send your responses to feedback@pharmavoice.com. And we will feature your comments and insights in a future issue. Biosimilars on the Horizon The Patient Protection and Affordable Care Act contains provisions that ­establish an ­abbreviated approval pathway for generic versions of biological medicines. And the FDA is moving ­forward; in November it held a public ­hearing to ­obtain input on specific issues and challenges. Top Innovators IDEA Pharma’s annual Productive Innovation Index (PII) ranks the Top 13 global pharma ­companies for commercial added value across their portfolios from 2005 to 2010. Ranking Company 1. Johnson & Johnson 2. Amgen 3. Lilly 4. Roche/Genentech 5. Sanofi-Aventis 6. Novartis 7. Pfizer 8. Abbott 9. Merck & Co. 10. GlaxoSmithKline 11. Bayer 12. AstraZeneca 13. Bristol-Myers Squibb

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK